Split doses of Methotrexate in patients with moderate to severe Psoriasis M.J.M. Rodríguez-Zúñiga, F. Cortez-Franco, E. Qujiano-Gomero

Tralokinumab Effectiveness in Moderate-to-severe Atopic Dermatitis With Palmoplantar Eczema J.J. Domínguez-Cruz, F.J. Navarro-Triviño, M. Galán-Gutiérrez, J.J. Pereyra-Rodríguez, J.C. Armario-Hita, R. Ruiz-Villaverde

Does the treatment ladder for systemic therapy in moderate to severe psoriasis only go up? The percentage of patients with severe psoriasis on biologics increases over time J.M. Carrascosa, N. Rivera, I. Garcia-Doval, G. Carretero, F. Vanaclocha, E. Daudén, F.J. Gómez-García, P. De-la-Cueva-Dobao, E. Herrera-Ceballos, I. Belinchón, M. Alsina, J.L. Sánchez-Carazo, M. Ferrán, J.L. Lopez-Estebaranz, B. Pérez-Zafrilla, M. Llamas, R. Rivera, C. Ferrándiz